GlassScriptPhysician profile
David J Schlam
NPI 1043232226
$1,225.35
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2021: $151 · 2022: $224 · 2023: $308 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $407.84 | 2019-2025 | Dart-Fire, Allowrap |
| Rikco International, LLC | $170.00 | 2019 | |
| Triad Life Sciences INC. | $116.10 | 2022 | |
| Wright Medical Technology, INC. | $109.17 | 2019 | |
| Treace Medical Concepts, INC. | $69.55 | 2022-2023 | |
| Resmed Corp | $64.61 | 2023 | |
| Djo, LLC | $49.92 | 2023 | Cmf |
| Paratek Pharmaceuticals, INC. | $49.12 | 2022-2023 | Nuzyra |
| Paragon 28, INC. | $31.53 | 2019 | |
| Merck Sharp & Dohme LLC | $29.15 | 2019 | |
| Next Science LLC | $27.40 | 2023 | Surgx, Xperience, Blastx |
| Kci USA, INC. | $25.44 | 2021 | |
| Convatec INC. | $21.75 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.40 | 2022 | |
| Medtronic, INC. | $16.71 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.66 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schlam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.